A carregar...

Oral platelet glycoprotein IIb/IIIa receptor inhibitors—part I

With the central importance of antiplatelet therapy in patients with coronary artery disease and the numerous positive trials with glycoprotein (GP) IIb/IIIa inhibitors given intravenously, it was hoped that one could extend the benefit of IIb/IIIa inhibition to long‐term treatment. Although the hyp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Autor principal: Cannon, Christopher P.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6654758/
https://ncbi.nlm.nih.gov/pubmed/12918637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4950260803
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!